Rankings
▼
Calendar
UTHR FY 2010 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
UTHR
United Therapeutics Corporation
$24B
FY 2010 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$604M
+63.3% YoY
Gross Profit
$530M
87.8% margin
Operating Income
$164M
27.2% margin
Net Income
$106M
17.5% margin
EPS (Diluted)
$1.78
Cash Flow
Operating Cash Flow
$212M
Free Cash Flow
$193M
Stock-Based Comp.
$114M
Balance Sheet
Total Assets
$1.4B
Total Liabilities
$548M
Stockholders' Equity
$884M
Cash & Equivalents
$252M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$604M
$370M
+63.3%
Gross Profit
$530M
$325M
+63.4%
Operating Income
$164M
$26M
+530.8%
Net Income
$106M
$19M
+444.2%
← FY 2009
All Quarters
FY 2011 →